20103 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Excipients; Inactive ingredients; Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Sustained release dosage form
#1802Melt-extruded solid dispersions containing an apoptosis-inducing agent
#1803FORMULATIONS FOR THE PREPARATION OF IMMEDIATE RELEASE TABLETS FOR ORAL ADMINISTRATION CONTAINING LOW-DOSE MIFEPRISTONE, TABLETS THUS OBTAINED AND THEIR PREPARATION PROCESS
#1804Pharmaceutical composition containing fimasartan and hydrochlorothiazide
#1805Palatable oral veterinary compositions
#1806GRANULATED COMPOSITE, RAPID RELEASE TABLET AND METHOD FOR PRODUCING SAME
#1807Pharmaceutical compositions of anti-viral compounds and process for preparation thereof
#1808Solid Pharmaceutical Compositions
#1809Once-a-day oxycodone formulations
#1810Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
#1811Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists
#1812Polyhydroxylated pentacyclic triterpene acids as HMG-COA reductase inhibitors
#1813Formulations of rifaximin and uses thereof
#1814Dry-coated tablet
#1815Multilayered dosage form
#1816Acamprosate formulations, methods of using the same, and combinations comprising the same
#1817Immediate release abuse-deterrent granulated dosage forms
#1818Immediate release abuse-deterrent granulated dosage forms
#1819Immediate Release Abuse-Deterrent Granulated Dosage Forms
#1820Orally disintegrating tablet and production process therefor
#1821Opioid agonist formulations with releasable and sequestered antagonist
#1822ENTERIC TABLET
#1823Gastric retentive tablet compositions
#1824High-loading, controlled-release magnesium oral dosage forms and methods for making and using same
#1825Nicotine Lozenge Composition
#1826Coating film, and granules and tablets each utilizing same
#1827Aliphatic amine polymer salts for tableting
#1828Use of Odiparcil in the treatment of a mucopolysaccharidosis
#1829Modified release preparations containing oxcarbazepine and derivatives thereof
#1830Solid pharmaceutical compositions containing pregabalin
#1831Modified release preparations containing oxcarbazepine and derivatives thereof
#1832Stabilized formulations of CNS compounds
#1833Pharmaceutical composition containing crystalline sorafenib tosylate
#1834Sustained release formulation of naltrexone
#1835Methods and compositions for deterring abuse
#1836VETERINARY COMPOSITIONS
#1837Lercanidipine Hydrochloride and Losartan Potassium Compound Preparation and Preparation Method Thereof
#1838USE OF MODAFINIL IN THE TREATMENT OF COCAINE ADDICTS
#1839FORMULATIONS
#1840NOVEL PHARMACEUTICAL FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE
#1841Abuse resistant forms of immediate release oxymorphone, method of use and method of making
#1842Abuse resistant forms of extended release hydrocodone, method of use and method of making
#1843Tamper Resistant Dosage Form Composition And Process Of Making The Same
#1844Tamper-resistant pharmaceutical dosage forms
#1845Abuse resistant forms of extended release oxymorphone, method of use and method of making
#1846Abuse resistant forms of immediate release hydromorphone, method of use and method of making
#1847Extruded immediate release abuse deterrent pill
#1848Pharmaceutical Composition Having Improved Dissolution Profiles For Poorly Soluble Drugs
#1849Pharmaceutical composition
#1850Direct compression polymer tablet core
#1851Drug delivery system
#1852Film-coated and/or granulated calcium-containing compounds and use therof in pharmaceutical compositions
#1853Solid pharmaceutical composition containing 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof
#1854Formulation of Syk inhibitors
#1855Solid ivabradine-containing composition
#1856Crystalline form of sitagliptin sulfate
#1857Orally Disintegrating Compositions of Linaclotide
#1858STABLIZED MODIFIED RELEASE FOLIC ACID DERIVATIVE COMPOSITION, ITS THERAPEUTIC USE AND METHODS OF MANUFACTURE
#1859Gastroretentive tablets
#1860Modified release formulations containing drug—ion exchange resin complexes
#1861PHASED DOSING OF CLOPIDOGREL
#1862TRANEXAMIC ACID FORMULATIONS
#1863Procaspase 3 activation by combination therapy
#1864Celecoxib compositions
#1865Controlled release and taste masking oral pharmaceutical composition
#1866COMBINED PHARMACEUTICAL FORMULATION CONTAINING DIACEREIN
#1867PREGABALIN GR TABLETS
#1868Formulations of phenyl uracil compounds
#1869Abuse resistant forms of extended release morphine, method of use and method of making
#1870Method and composition for enhancing cognition in alzheimer's patients
#1871Controlled release hydrocodone formulations
#1872BOSENTAN CONTROLLED RELEASE ORAL PREPARATION
#1873Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
#1874Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
#1875Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof
#1876Pharmaceutical compositions of lurasidone
#1877Orally dispersible tablet containing compacted sildenafil base
#1878Pharmaceutical composition comprising licarbazepine acetate
#1879Controlled release formulations of nisoldipine
#1880Abuse deterrent compositions and methods of making same
#1881Aqueous polymer dispersion based on N,N-diethylaminoethyl methacrylate, its preparation and use
#1882PHARMACEUTICAL COMPOSITION
#1883Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof
#1884Peptide pharmaceutical for oral delivery
#1885Dosage form for insertion into the mouth
#1886Dosage form for insertion into the mouth
#1887Composition comprising solanum glaucophyllum for preventing and/or treating hypocalcaemia and for stabilizing blood calcium levels
#1888Tablet capable of combatting misuse by injection
#1889Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
#1890PHARMACEUTICAL COMPOSITIONS COMPRISING RIVAROXABAN
#1891CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS WITH IMPROVED BIOAVAILABILILTY
#1892Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
#1893Oral disintegrating tablet
#1894Solid retard formulations based on solid dispersions
#1895Modified release compositions of epalrestat or a derivative thereof and methods for using the same
#1896Solid dispersions of a ERB2 (HER2) inhibitor
#1897Misuse preventative, controlled release formulation
#1898Misuse preventative, controlled release formulation
#1899Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases
#1900Methylphenidate extended release chewable tablet
#1901Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#1902Tamper resistant pharmaceutical formulations
#1903Drug delivery system to increase bioavailability
#1904SOVAPREVIR TABLETS
#1905Controlled release hydrocodone formulations
#1906Dosage form for insertion into the mouth
#1907Dosage form for insertion into the mouth
#1908Chewable enteric coated aspirin tablets
#1909Abuse resistant forms of extended release morphine, method of use and method of making
#1910Abuse resistant forms of extended release morphine, method of use and method of making
#1911Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
#1912Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
#1913Tamper resistant pharmaceutical formulations
#1914Reduction of opioid blood fluctuations
#1915Crystal entecavir, crystal entecavir formulation and methods for the preparation thereof
#1916Pharmaceutical composition with improved bioavailability
#1917Polymorphs of darunavir
#1918Pharmaceutical dosage form comprising polymeric carrier composition
#1919Controlled release hydrocodone
#1920Abuse-resistant controlled-release opioid dosage form
#1921Taste-masked pharmaceutical compositions containing diclofenac
#1922Intrabuccally rapidly disintegrating tablet and a production method of the tablets
#1923Misuse preventative, controlled release formulation
#1924Dual drug dosage forms with improved separation of drugs
#1925Sustained-release preparation of ivabradine or pharmaceutically acceptable salts thereof
#1926Solid pharmaceutical compositions containing pregabalin
#1927Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
#1928Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
#1929Methods and compositions for self-regulated release of active pharmaceutical ingredient
#1930Conformal coating of cells for immunoisolation
#1931Abuse-resistant controlled-release opioid dosage form
#1932Aripiprazole medicament formulation and preparation method therefor
#1933Pharmaceutical composition
#1934RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION
#1935Antifungal compositions with improved bioavailability
#1936Polymer release system
#1937Formulations of pyrimidinedione derivative compounds
#1938Modified release formulations for oprozomib
#1939Pharmaceutical Composition and Administrations Thereof
#1940Gastroresistant pharmaceutical formulations containing rifaximin
#1941Controlled release hydrocodone formulations
#1942Abuse-resistant controlled-release opioid dosage form
#1943Compositions comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and process for preparing them
#1944Modified release preparations containing oxcarbazepine and derivatives thereof
#1945CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#1946Process for producing a solid dispersion of an active ingredient
#1947Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein
#1948Process for producing a solid dispersion of an active ingredient
#1949Abuse-proofed dosage forms
#1950Coating composition suitable for pharmaceutical or nutraceutical dosage forms
#1951Modified release compositions comprising tacrolimus
#1952Modified release compositions comprising tacrolimus
#1953Saccharide conjugates
#1954Modified release compositions comprising tacrolimus
#1955SOLID PHARMACEUTICAL COMPOSITION CONTAINING 6-OXO-6,7,8,9,10,11-HEXAHYDROCYCLOHEPTA (C)CHROMEN-3-YL SULFAMATE AND POLYMORPHS THEREOF
#1956Pharmaceutical for oral delivery comprising MGBG and methods of treating disease
#1957Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof
#1958Binder powders
#1959Tablet Of Paracetamol Containing An Encapsulated Flavorant
#1960Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
#1961Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
#1962Extended release, abuse deterrent pharmaceutical compositions
#1963Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
#1964Pharmaceutical composition
#1965Acamprosate formulations, methods of using the same, and combinations comprising the same
#1966Acamprosate formulations, methods of using the same, and combinations comprising the same
#1967Opiod agonist formulations with releasable and sequestered antagonist
#1968Mucosal bioadhesive slow release carrier for delivering active principles
#1969Flashmelt oral dosage formulation
#1970Controlled release hydrocodone
#1971Tamper resistant and dose-dumping resistant pharmaceutical dosage form
#1972MICROSPHERE DRUG CARRIER, PREPARATION METHOD, COMPOSITION AND USE THEREOF
#1973Orally disintegrating tablet
#1974Pharmaceutical compositions of linezolid
#1975Alcohol-resistant metoprolol-containing extended-release oral dosage forms
#1976Pharmaceutical formulations comprising CCR3 antagonists
#1977Daily formulation of lacosamide
#1978Solid pharmaceutical compositions of ppary modulator
#1979High-loading, controlled-release magnesium oral dosage forms and methods for making and using same
#1980Antimalarial drug comprising alaremycin or derivative thereof as active ingredient
#1981Combination of active loaded granules with additional actives
#1982Parenteral formulations of dopamine agonists
#1983Pharmaceutical compositions comprising hydromorphone and naloxone
#1984Co-processed tablet excipient composition its preparation and use
#1985Manufacturing of active-free granules and tablets comprising the same
#1986Aildenafil citrate crystal form O, preparation method and use thereof
#1987Shell-and-core dosage form approaching zero-order drug release
#1988Controlled release hydrocodone
#1989Ferrimannitol-ovalbumin tablet composition
#1990Neramexane multiple unit dosage form
#1991[1,2,3]triazolo[4,5-D]pyrimidine derivatives
#1992High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
#1993Treatment of type 1 diabetes
#1994Solid drug tablets for implantable drug delivery devices
#1995Method and composition to improve absorption of therapeutic agents
#1996Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases
#1997Pharmaceutical compositions of co-crystals of tramadol and coxibs
#1998Method of treating diabetes
#1999FORMULATIONS COMPRISING COATED FINE PARTICLES
#2000PHARMACEUTICAL COMPOSITIONS COMPRISING PHOSPHATE BINDER, CALCIUM RECEPTOR-ACTIVE COMPOUND AND/OR ACTIVE VITAMIN D
#2001WOUND HEALING COMPOSITIONS AND METHODS
#2002ORALLY DISPERSIBLE TABLET
#2003Dosage form for insertion into the mouth
#2004Modified release formulations containing drug-ion exchange resin complexes
#2005Oral drug delivery system
#2006SUSTAINED RELEASE DONEPEZIL FORMULATIONS
#2007Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use
#2008Methods of administering antihistamines
#2009CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITION
#2010Tuberculosis drug based on 4-thioureido-iminomethylpyridinium perchlorate: method of preparation and treatment
#2011Aminotetralin compounds as mu opioid receptor antagonists
#2012Orally dispersible tablet
#2013Orally dispersible tablet
#2014Prasugrel in micronized, crystalline form and pharmaceutical composition thereof
#2015EXTENDED RELEASE FORMULATIONS OF DESVENLAFAXINE BASE
#2016Peptide pharmaceutical for oral delivery
#2017Pharmaceutical preparation comprising phenylalanine derivative
#2018SUSTAINED RELEASE ORAL MATRIX AND METHODS OF MAKING THEREOF
#2019NOVEL COMPOSITION FOR TREATMENT OF ESSENTIAL THROMBOCYTHEMIA
#2020Solid pharmaceutical dosage form of ticagrelor
#2021Controlled release and taste masking oral pharmaceutical composition
#2022Tranexamic acid formulations
#2023Tranexamic acid formulations
#2024Method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
#2025Stabilized prolonged release pharmaceutical composition comprising atypical antipsychotic
#2026FORMULATIONS OF MAZINDOL
#2027METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS
#2028METHODS FOR TREATING HYPERLIPIDEMIA WITH INTERMEDIATE RELEASE NICOTINIC ACID COMPOSITIONS HAVING UNIQUE BIOPHARMACEUTICAL CHARACTERISTICS
#2029QUININE DOSAGE FORMS AND METHODS OF USE THEREOF
#2030SUSTAINED-RELEASE SOLID PREPARATION FOR ORAL USE
#2031Solid Pharmaceutical Dosage Formulation
#2032SUSTAINED-RELEASE SOLID PREPARATION FOR ORAL USE
#2033SLOW RELEASE PHARMACEUTICAL COMPOSITIONS OF ILOPERIDONE
#2034Utilization of dialkylfumarates
#2035Gastroretentive, extended release composition of therapeutic agent
#2036Coating composition
#2037PHARMACEUTICAL COMPOSITION OF DONEPEZIL
#2038Mucosal bioadhesive slow release carrier for delivering active principles
#2039Active Agent Formulations, Methods of Making, and Methods of Use
#2040MUCOSAL BIOADHESIVE SLOW RELEASE CARRIER FOR DELIVERING ACTIVE PRINCIPLES
#2041Direct Compression Polymer Tablet Core
#2042Pharmaceutical formulations of modafinil
#2043VETERINARY COMPOSITIONS
#2044Production method of solid preparation and the solid preparations produced by the method
#2045TABLETED COMPOSITIONS CONTAINING ATAZANAVIR
#2046Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (C)chromen-3-yl sulfamate and polymorphs thereof
#2047DIRECT COMPRESSION POLYMER TABLET CORE
#2048Controlled Release and Taste Masking Oral Pharmaceutical Composition
#2049Technology for Preventing Abuse of Solid Dosage Forms
#2050Pharmaceutical formulations of modafinil
#2051Extended release preparation
#2052Peptide pharmaceutical for oral delivery
#2053Polymorphs of Dasatinib, preparation methods and pharmaceutical compositions thereof
#2054Controlled release and taste making oral pharmaceutical composition
#2055Pharmaceutical Compositions Having Improved Dissolution Profiles For Poorly Soluble Drugs
#2056Layer processing for pharmaceuticals
#2057COMPOSITION COMPRISING SOLANUM GLAUCOPHYLLUM FOR PREVENTING AND/OR TREATING HYPOCALCAEMIA AND FOR STABILIZING BLOOD CALCIUM LEVELS
#2058Orodispersible tablet containing compacted sildenafil base
#2059DRUG CARRIER WITH THERMAL SENSITIVITY, MANUFACTURING METHOD THEREOF, AND USE THEREOF
#2060Methods of treating pain with MGBG
#2061Pharmaceutical compositions comprising colloidal silicon dioxide
#2062Opioid agonist formulations with releasable and sequestered antagonist
#2063Amorphous darunavir
#2064Modified Release Formulation
#2065RAPIDLY DISPERSING GRANULES, ORALLY DISINTEGRATING TABLETS AND METHODS
#2066ORALLY DISPERSIBLE TABLET
#2067Compositions and methods for treatment of pouchitis
#2068Pharmaceutical compositions of raltegravir, methods of preparation and methods of use therof
#2069METHOD FOR THE TREATMENT, ALLEVIATION OF SYMPTOMS OF, RELIEVING, IMPROVING AND PREVENTING A COGNITIVE DISEASE, DISORDER OR CONDITION
#2070Dual drug dosage forms with improved separation of drugs
#2071FOMULATION COMPRISING 1 H-QUINAZOLINE-2, 4-DIONE AMPA RECEPTOR ANTAGONISTS, IN THE FORM OF IMMEDIATE RELEASE TABLETS AND PREPARATION THEREOF
#2072Controlled release hydrocodone formulations
#2073Solid compositions
#2074ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM
#2075ORAL LYSOPHILISATES CONTAINING PVP/VA
#2076Abuse-proofed dosage form
#2077Traditional Chinese drug comprising Danshen extracts and Sanqi extracts and use thereof
#2078Controlled release carvedilol formulation
#2079NICOTINIC ACID COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND RELATED METHODS THEREFOR
#2080PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE
#2081Orally dispersible tablet
#2082Pharmaceutical composition containing irbesartan
#2083Pharmaceutical Compositions Comprising Mycophenolic Acid or Mycophenolate Salt
#2084CONTROLLED RELEASE DOSAGE FORMS
#2085SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALIN
#2086Modified release preparations containing oxcarbazepine and derivatives thereof
#2087CONTROLLED RELEASE DOSAGE FORMS
#2088CONTROLLED RELEASE DOSAGE FORMS
#2089PHARMACEUTICAL COMPOSITIONS COMPRISING RIVAROXABAN
#2090Pharmaceutical Formulation For Producing Rapidly Disintegrating Tablets
#2091Articles and processes for making a porous disintegratable solid substrate for personal health care applications
#2092Mucoadhesive polymers having vitamin B partial structures
#2093Controlled Release and Taste Masking Oral Pharmaceutical Composition
#2094DPP IV INHIBITOR FORMULATIONS
#2095PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
#2096Controlled release and taste masking oral pharmaceutical composition
#2097Moisture Resistant Container Systems for Rapidly Bioavailable Dosage Forms
#2098Solid Oral Dosage Form Attached to a Handle
#2099METHODS FOR TREATING HYPERLIPIDEMIA WITH INTERMEDIATE RELEASE NICOTINIC ACID COMPOSITIONS HAVING UNIQUE BIOPHARMACEUTICAL CHARACTERISTICS
#2100METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS